By Nigam Arora & Dr. Natasha Arora
308% Gain
JOBY is long from $5.06. It is trading at $20.64 as of this writing, representing a 308% gain.
Acquisition
eVTOL company Joby Aviation (JOBY) has acquired the passenger division of air transportation and logistics services company Blade Air Mobility (BLDE).
JOBY stock is jumping 20% on the news as of this writing.
Blade Medical Division
The medical division of Blade Air Mobility will rebrand as Strata. Strata and Joby have a long-term partnership.
Ten Bagger
JOBY stock has the potential to be a ten bagger.
eVTOL
eVTOL stands for electric vertical take off and landing. The pop culture term is flying cars. eVTOL aircraft are designed for shorter flights and may be useful as air taxis, for cargo delivery, and in emergency response.
JOBY is a premier player with backing from Toyota (TM).
What To Do Now
Those in JOBY stock may consider continuing to hold.
Those not in JOBY stock may consider waiting for a new signal.
Signal Limited is a Signal(s) with a great record in similar situations but does not meet all of the stringent criteria for a Signal. Typically Signal Limited has higher risk-reward compared to a Signal over the short term.
To take a free 30-day trial to paid services to gain access to more opportunities, please click here.
This post was just published on ZYX Buy Change Alert.
Markets can generate substantial wealth for knowledgeable investors. NOW YOU TOO CAN ALSO SPECTACULARLY SUCCEED AT MEETING YOUR GOALS WITH THE HELP OF THE ARORA REPORT. You are receiving less than 1% of the content from our paid services. …TO RECEIVE REMAINING 99%, INCLUDING MANY ATTRACTIVE INVESTMENT OPPORTUNITIES AND SIGNALS IN REAL TIME, TAKE A FREE
TRIAL TO PAID SERVICES.
The Arora Report is one of the only major global investment newsletters that does not employ a single salesperson—because it does not need to. While competitors rely on high-pressure sales tactics, The Arora Report grows purely through results, with satisfied members recommending it to their family and friends.
Join the service that investors trust the most and recommend to family and friends.
Please click here to take advantage of a FREE 30 day trial.

Nigam Arora
Nigam Arora is known for his accurate stock market calls. Nigam is a distinguished master of the macro. He is a popular columnist with over 100 million page views, an engineer, and nuclear physicist by background. Nigam has founded two Inc. 500 fastest growing companies and has been involved in over 50 entrepreneurial ventures. He is the developer of Theory ZYX of Successful Change Management and is the author of the book on Theory ZYX, as well as the developer of the ZYX Change Method for Investing.

Dr. Natasha Arora
Dr. Natasha Arora has significant expertise in investment analysis especially biotech, healthcare, and technology. Natasha is a graduate of Harvard Medical School followed by a postdoc at MIT. She has published several peer reviewed research papers in top science journals.